Sintilimab Plus AVD in Pediatric Low/Moderate Risk Hodgkin Lymphoma: A Phase II Study

Clinical trial NCT06848569 · RECRUITING

Trial details

NCT number: NCT06848569
Sponsor: Sun Yat-sen University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Classical Hodgkin Lymphoma

Start date: 2024-10-23
Primary completion: 2027-10-23
Enrollment: 73

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.